Coloplast A/S

CPSE:COLO B 주식 보고서

시가총액: DKK 187.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Coloplast 관리

관리 기준 확인 4/4

Coloplast's CEO는 Kristian Villumsen, Dec2018 에 임명되었습니다 의 임기는 5.5 년입니다. 총 연간 보상은 DKK 23.30M, 51.5% 로 구성됩니다. 51.5% 급여 및 48.5% 보너스(회사 주식 및 옵션 포함). 는 DKK 82.90M 가치에 해당하는 회사 주식의 0.045% 직접 소유합니다. 82.90M. 경영진과 이사회의 평균 재임 기간은 각각 6.2 년과 6.4 년입니다.

주요 정보

Kristian Villumsen

최고 경영자

DKK 23.3m

총 보상

CEO 급여 비율51.5%
CEO 임기5.6yrs
CEO 소유권0.05%
경영진 평균 재임 기간6.3yrs
이사회 평균 재임 기간6.5yrs

최근 관리 업데이트

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Recent updates

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jun 29
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Coloplast (CPH:COLO B) Could Easily Take On More Debt

Jan 12
Coloplast (CPH:COLO B) Could Easily Take On More Debt

Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Dec 28
Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Oct 31
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Oct 02
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Sep 16
Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Aug 02
Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Jul 01
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Jun 16
Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

CEO 보상 분석

Kristian Villumsen 의 보수는 Coloplast 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

DKK 5b

Dec 31 2023n/an/a

DKK 5b

Sep 30 2023DKK 23mDKK 12m

DKK 5b

Jun 30 2023n/an/a

DKK 5b

Mar 31 2023n/an/a

DKK 5b

Dec 31 2022n/an/a

DKK 5b

Sep 30 2022DKK 21mDKK 12m

DKK 5b

Jun 30 2022n/an/a

DKK 5b

Mar 31 2022n/an/a

DKK 5b

Dec 31 2021n/an/a

DKK 5b

Sep 30 2021DKK 22mDKK 11m

DKK 5b

Jun 30 2021n/an/a

DKK 5b

Mar 31 2021n/an/a

DKK 4b

Dec 31 2020n/an/a

DKK 4b

Sep 30 2020DKK 20mDKK 11m

DKK 4b

Jun 30 2020n/an/a

DKK 4b

Mar 31 2020n/an/a

DKK 4b

Dec 31 2019n/an/a

DKK 4b

Sep 30 2019DKK 17mDKK 10m

DKK 4b

Jun 30 2019n/an/a

DKK 4b

Mar 31 2019n/an/a

DKK 4b

Dec 31 2018n/an/a

DKK 4b

Sep 30 2018DKK 11mDKK 6m

DKK 4b

Jun 30 2018n/an/a

DKK 4b

Mar 31 2018n/an/a

DKK 4b

Dec 31 2017n/an/a

DKK 4b

Sep 30 2017DKK 10mDKK 6m

DKK 4b

보상 대 시장: Kristian 의 총 보상 ($USD 3.36M )은 Danish 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 4.19M ).

보상과 수익: Kristian 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Kristian Villumsen (54 yo)

5.6yrs

테뉴어

DKK 23,300,000

보상

Mr. Kristian Villumsen has been Independent Director of Demant A/S since March 5, 2021. He has been the President and Chief Executive Officer of Coloplast A/S since December 4, 2018. Mr. Villumsen was an E...

리더십 팀

이름위치테뉴어보상소유권
Kristian Villumsen
President & CEO5.6yrsDKK 23.30m0.045%
DKK 84.3m
Anders Lonning-Skovgaard
Executive VP & CFO10yrsDKK 11.90m0.0012%
DKK 2.2m
Allan Rasmussen
Executive Vice President of Global Operations10yrsDKK 10.50m0%
DKK 0
Nicolai Andersen
Executive Vice President of Innovationno dataDKK 10.00m데이터 없음
Paul Marcun
Executive Vice President of Growth5.5yrsDKK 12.00m데이터 없음
Thomas Barfod
Senior Controller & Employees Representative Directorno dataDKK 450.00k0.000020%
DKK 37.4k
Ellen Bjurgert
Vice President of Investor Relations7.8yrs데이터 없음데이터 없음
Dennis Kaysen
Director of Corporate Communicationsno data데이터 없음데이터 없음
Dorthe Ronnau
Senior Vice President of People & Culture2.5yrs데이터 없음데이터 없음
Alain Morvan
Senior Vice President of Sales Europe12.3yrs데이터 없음데이터 없음
Rasmus Møller
Senior Vice President of Wound & Skin Care3.8yrs데이터 없음데이터 없음
Manu Varma
Senior Vice President of Chronic Care - North America6.3yrs데이터 없음데이터 없음

6.3yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: COLO B 의 관리팀은 노련하고 경험 (평균 재직 기간 6.2 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Thomas Barfod
Senior Controller & Employees Representative Director18.5yrsDKK 450.00k0.000020%
DKK 37.4k
Carsten Hellmann
Independent Director6.6yrsDKK 690.00k0.0027%
DKK 5.0m
Lars Rasmussen
Chairman of the Board5.6yrsDKK 1.84m0.092%
DKK 172.6m
Niels Louis-Hansen
Deputy Chairman56.5yrsDKK 938.00k1.93%
DKK 3.6b
Marianne Wiinholt
Independent Director3.6yrsDKK 880.00k0.00022%
DKK 411.5k
Jette Nygaard-Andersen
Independent Director8.6yrsDKK 600.00k데이터 없음
Nikolaj Gundersen
Employees Representative Director6.5yrsDKK 450.00k데이터 없음
Roland Pedersen
Employees Representative Director6.5yrsDKK 450.00k0.00072%
DKK 1.3m
Annette Bruls
Independent Director2.6yrsDKK 600.00k데이터 없음

6.5yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 이사회: COLO B 의 이사회는 경험(평균 재직 기간 6.4 년)으로 간주됩니다.